PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 6 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

12 June 2026

  1. (diff | hist) m 11:20 Preparative HPLC purification 4,882 ±0 FmocFrancis (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  2. (diff | hist) 10:26 Amino acid analysis 4,943 ±0 DisparityDagny (talk | contribs) typo [rollback]
  3. (diff | hist) 10:20 Talk:Drug master file 537 +162 VerifyVesna (talk | contribs) /* Same shape as other claims */ new section
  4. (diff | hist) m 09:44 Glucagon 7,074 ±0 DiagramDelphine (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  5. (diff | hist) 09:43 Retention time 4,104 ±0 BPC_Bramwell (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  6. (diff | hist) 09:39 Batch number 4,573 ±0 DeletionDeb (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  7. (diff | hist) 06:41 Incretin effect 7,358 ±0 GIP_Genoveva (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  8. (diff | hist) 02:27 Shenzhen Hybio Pharmaceutical 17,716 ±0 ReportReaderRilla (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  9. (diff | hist) m b 01:06 Personal importation policy 4,121 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]

11 June 2026

  1. (diff | hist) m b 23:47 Cold-chain freight 4,758 ±0 CiteBot (talk | contribs) bot: normalise temperature formatting [rollback]
  2. (diff | hist) 17:08 Number needed to treat 4,718 ±0 SelectTrialSam (talk | contribs) de-duplicate a repeated sentence [rollback]
  3. (diff | hist) 15:40 Talk:Dipeptidyl peptidase-4 885 +183 MolarMassMaeve (talk | contribs) /* Table row for lixisenatide? */ reply
  4. (diff | hist) 15:00 Talk:Bacterial endotoxin test 885 +122 DisclosureDido (talk | contribs) /* Absence of the determination */ reply
  5. (diff | hist) 14:05 Talk:Sarcopenia 748 +108 ClinicCorrespondent (talk | contribs) /* Extrapolating the exercise evidence */ reply
  6. (diff | hist) 12:54 Sharps disposal 15,972 +1,295 SyringeSybille (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  7. (diff | hist) 12:02 Resin cleavage 4,310 ±0 SPPS_Sorrel (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  8. (diff | hist) 11:35 Talk:Bacterial endotoxin test 674 +180 BalanceBirdie (talk | contribs) /* Absence of the determination */ new section
  9. (diff | hist) 11:22 Talk:Dipeptidyl peptidase-4 674 +155 ListMakerLumi (talk | contribs) /* Table row for lixisenatide? */ new section
  10. (diff | hist) 10:30 Talk:Sarcopenia 537 +169 HedgeHedda (talk | contribs) /* Extrapolating the exercise evidence */ new section
  11. (diff | hist) 09:20 Janoshik Analytical 5,235 ±0 GIP_Genoveva (talk | contribs) add the cross-link to the traceability article [rollback]
  12. (diff | hist) m 07:38 TRIUMPH trial programme 4,703 ±0 GramsNotUnitsGil (talk | contribs) rm the survival claim — no mortality endpoint was pre-specified [rollback]
  13. (diff | hist) m 04:32 Contraindications of incretin therapy 4,993 ±0 NeutralNikolai (talk | contribs) attribute the boxed-warning statement to the regulator that issued it [rollback]
  14. (diff | hist) 04:11 Dulaglutide 5,490 ±0 DulaglutideDug (talk | contribs) rm the comparison to a compound with no published head-to-head data [rollback]

10 June 2026

  1. (diff | hist) 20:53 Glucose-dependent insulinotropic polypeptide 8,265 ±0 ReportReaderRilla (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) 17:04 Dipeptidyl peptidase-4 7,022 ±0 Areapercent_Ayo (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) 15:46 Bacteriostatic water 4,652 ±0 ReaderRosalie (talk | contribs) expand §Interaction with peptides [rollback]
  4. (diff | hist) 14:50 Talk:STEP trial programme 885 +143 DataTableDunja (talk | contribs) /* The mean describes nobody */ reply
  5. (diff | hist) 12:33 Triple agonist 4,269 ±0 OrforglipronOona (talk | contribs) expand §Why three receptors [rollback]
  6. (diff | hist) 11:15 Talk:STEP trial programme 674 +140 ForestPlotFinn (talk | contribs) /* The mean describes nobody */ new section
  7. (diff | hist) m 09:17 SURMOUNT trial programme 5,021 ±0 AppendixAlva (talk | contribs) add the year of publication to each trial in the list [rollback]
  8. (diff | hist) 08:52 Talk:Multi-dose vial 1,581 +127 LabelLibby (talk | contribs) /* Preservative concentration table: are these current products or historical? */ reply
  9. (diff | hist) 06:10 Insulin secretion 6,940 ±0 ProglucagonPia (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  10. (diff | hist) 03:44 Qingdao Saber Technology Pharmaceutical 14,592 ±0 VerifyVesna (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  11. (diff | hist) 03:00 Intention-to-treat analysis 4,963 ±0 Compounding_Cate (talk | contribs) rm the survival claim — no mortality endpoint was pre-specified [rollback]
  12. (diff | hist) m 02:45 List of GLP-1 receptor agonists 3,862 ±0 PortalPolly (talk | contribs) expand §Related compounds [rollback]
  13. (diff | hist) m 02:00 Enteroendocrine L cell 5,083 ±0 PreregPriya (talk | contribs) add the postprandial time course with its units [rollback]
  14. (diff | hist) 01:45 Prescribing information 4,506 ±0 TierTwoTansy (talk | contribs) clarify that a discontinued shortage listing changed the compounding position [rollback]

9 June 2026

  1. (diff | hist) m b 20:56 Growth hormone secretagogue 4,613 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) 13:55 Talk:Retention time 748 +101 COA_Colwyn (talk | contribs) /* Within-system value */ reply
  3. (diff | hist) 13:50 Talk:Purity claim inflation 885 +179 VerifyVesna (talk | contribs) /* Checkability as the criterion */ reply
  4. (diff | hist) 10:25 Talk:Purity claim inflation 674 +182 COA_Colwyn (talk | contribs) /* Checkability as the criterion */ new section
  5. (diff | hist) 10:20 Talk:Retention time 537 +135 IsocraticIla (talk | contribs) /* Within-system value */ new section
  6. (diff | hist) 09:35 Talk:Peptide 1,096 +60 ScopeSeverin (talk | contribs) /* Scope creep */ reply
  7. (diff | hist) 09:17 Talk:Multi-dose vial 1,370 +239 PharmDrafts (talk | contribs) /* Preservative concentration table: are these current products or historical? */ reply
  8. (diff | hist) 04:38 Sterile water for injection 4,738 ±0 DeadSpaceDot (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  9. (diff | hist) 01:25 Sharps disposal 14,677 +234 SemaxSevi (talk | contribs) space between number and unit per PP:MOS [rollback]

8 June 2026

  1. (diff | hist) 23:29 Aspiration risk under anaesthesia 4,681 ±0 RegainRomilly (talk | contribs) expand §The mechanism and its magnitude [rollback]
  2. (diff | hist) m 22:16 Zhuhai Kerui Biotechnology 14,711 ±0 BatchNumberBede (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  3. (diff | hist) 15:05 Talk:Peptide 885 +203 Chromatokid (talk | contribs) /* Scope creep */ reply
  4. (diff | hist) 14:15 Talk:TRIUMPH trial programme 748 +213 RetatrutideRuben (talk | contribs) /* Heart-rate signal */ reply
  5. (diff | hist) 14:03 Talk:Multi-dose vial 1,159 +286 EndotoxinEd (talk | contribs) /* Preservative concentration table: are these current products or historical? */ reply
  6. (diff | hist) 11:26 Talk:Multi-dose vial 948 +286 LabelLibby (talk | contribs) /* Preservative concentration table: are these current products or historical? */ new section
  7. (diff | hist) 11:20 Talk:Peptide 674 +189 ScopeSeverin (talk | contribs) /* Scope creep */ new section
  8. (diff | hist) 10:40 Talk:TRIUMPH trial programme 537 +123 SafetySignalSid (talk | contribs) /* Heart-rate signal */ new section
  9. (diff | hist) m 09:40 Injection site rotation 4,872 ±0 COA_Colwyn (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]
  10. (diff | hist) m 09:10 Syringe dead space 20,968 ±0 CarryOverCai (talk | contribs) add the cross-link to the calculator page [rollback]

7 June 2026

  1. (diff | hist) 21:23 AmbioPharm 17,173 ±0 CheckSumChase (talk | contribs) de-duplicate a repeated sentence [rollback]
  2. (diff | hist) 14:05 Talk:USP General Chapter 71 748 +172 FiveOhThreeA (talk | contribs) /* Reference to compounding chapter */ reply
  3. (diff | hist) 10:30 Talk:USP General Chapter 71 537 +150 Compounding_Cate (talk | contribs) /* Reference to compounding chapter */ new section

6 June 2026

  1. (diff | hist) 19:51 Satiety signalling 5,593 ±0 GlossaryGleb (talk | contribs) add the cleavage site by residue number [rollback]
  2. (diff | hist) 17:34 Sharps disposal 14,443 +1,334 Hedgerow_Hal (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  3. (diff | hist) 15:52 Lixisenatide 4,195 ±0 Chromatokid (talk | contribs) expand §Current position [rollback]
  4. (diff | hist) m 15:10 Limit of detection 4,865 ±0 ResolutionRoo (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  5. (diff | hist) 03:38 SinoPep 18,360 ±0 GroupBuyGalen (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]

5 June 2026

  1. (diff | hist) 15:20 Talk:Janoshik Analytical 885 +191 COA_Colwyn (talk | contribs) /* Should content determination be described as an option? */ reply
  2. (diff | hist) 15:00 Talk:Peptide aggregation 885 +126 LyophilLena (talk | contribs) /* Handling practices */ reply
  3. (diff | hist) 14:00 Talk:C-peptide 748 +84 PuffRemoverPax (talk | contribs) /* Measured on treatment */ reply
  4. (diff | hist) 13:50 Talk:Regulatory status by jurisdiction 748 +89 GreyMarketGreer (talk | contribs) /* Presentation test */ reply
  5. (diff | hist) m 13:47 Xi'an Mokemei Biotechnology 15,421 ±0 Areapercent_Ayo (talk | contribs) state what the certificate supplied with orders carries [rollback]
  6. (diff | hist) m 12:30 SUSTAIN trial programme 5,153 ±0 DeadSpaceDot (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]
  7. (diff | hist) 11:30 Talk:Peptide aggregation 674 +175 NPOV_Nadia (talk | contribs) /* Handling practices */ new section
  8. (diff | hist) 11:15 Talk:Janoshik Analytical 674 +166 ReportReaderRilla (talk | contribs) /* Should content determination be described as an option? */ new section
  9. (diff | hist) 10:25 Talk:C-peptide 537 +174 BetaCellBoyd (talk | contribs) /* Measured on treatment */ new section
  10. (diff | hist) 10:15 Talk:Regulatory status by jurisdiction 537 +167 LabelLibby (talk | contribs) /* Presentation test */ new section
  11. (diff | hist) 03:52 Sharps disposal 13,109 +1,580 UnitAuditUwe (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]

4 June 2026

  1. (diff | hist) 16:27 Glossary of peptide terminology 4,744 ±0 MetricMabel (talk | contribs) move the prose introduction above the table [rollback]
  2. (diff | hist) 14:55 Talk:Sharps disposal 1,033 +199 HarmReductionHen (talk | contribs) /* Register: §Improvised containers reads as instruction */ reply
  3. (diff | hist) 14:07 GenScript Peptides 17,833 ±0 BlankVialBo (talk | contribs) fix a dangling clause [rollback]
  4. (diff | hist) 13:40 Talk:Grey market 748 +131 ChainCustodyChad (talk | contribs) /* Unknown is not bad */ reply
  5. (diff | hist) 12:40 Talk:Dulaglutide 885 +135 Chromatokid (talk | contribs) /* Reverse-phase purity on a fusion protein */ reply
  6. (diff | hist) 12:01 Shanghai Wibson Biotechnology 15,440 ±0 AnalyticalAnnie (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  7. (diff | hist) 10:05 Talk:Grey market 537 +104 BalanceBirdie (talk | contribs) /* Unknown is not bad */ new section
  8. (diff | hist) 09:15 Talk:Dulaglutide 674 +180 Areapercent_Ayo (talk | contribs) /* Reverse-phase purity on a fusion protein */ new section

3 June 2026

  1. (diff | hist) 14:45 Talk:Mass spectrometry 885 +141 MassSpecMarv (talk | contribs) /* Poorly ionising impurities */ reply
  2. (diff | hist) 11:20 Talk:Mass spectrometry 674 +195 SigFigSindri (talk | contribs) /* Poorly ionising impurities */ new section
  3. (diff | hist) 08:32 Talk:Sharps disposal 822 +106 Hedgerow_Hal (talk | contribs) /* Register: §Improvised containers reads as instruction */ reply
  4. (diff | hist) m 06:27 PolyPeptide Group (Hangzhou) 18,363 ±0 UnitsUrsula (talk | contribs) typo [rollback]
  5. (diff | hist) 02:36 Certificate of analysis 10,014 ±0 FmocFrancis (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]
  6. (diff | hist) 01:55 Peptide harm reduction 4,800 ±0 PBM_Perrin (talk | contribs) add the equity point with the study that measured it [rollback]
  7. (diff | hist) 01:45 Sharps disposal 11,529 +492 KarlFischerKit (talk | contribs) give the worked example to two significant figures throughout [rollback]

2 June 2026

  1. (diff | hist) 15:26 Customs seizure 4,785 ±0 LabelLibby (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  2. (diff | hist) 15:02 Talk:Insulin secretion 1,096 +86 HOMA_Hettie (talk | contribs) /* Which secretion index should the article recommend? */ reply
  3. (diff | hist) 13:50 Talk:Growth hormone secretagogue 748 +106 HedgeHedda (talk | contribs) /* Thin evidence base */ reply
  4. (diff | hist) 13:15 Talk:Active pharmaceutical ingredient 748 +90 VerifyVesna (talk | contribs) /* Same line as pharmaceutical material */ reply
  5. (diff | hist) 12:44 Talk:Insulin secretion 885 +132 NPOV_Nadia (talk | contribs) /* Which secretion index should the article recommend? */ reply
  6. (diff | hist) 12:18 Talk:Sharps disposal 611 +295 SharpsSukhi (talk | contribs) /* Register: §Improvised containers reads as instruction */ reply
  7. (diff | hist) m 11:50 Hypoglycaemia 4,473 ±0 SurvodutideSaff (talk | contribs) fix hyphenation per PP:MOS [rollback]
  8. (diff | hist) 10:30 Talk:Insulin secretion 674 +79 HOMA_Hettie (talk | contribs) /* Which secretion index should the article recommend? */ new section
  9. (diff | hist) 10:15 Talk:Growth hormone secretagogue 537 +131 PrimarySrcPatia (talk | contribs) /* Thin evidence base */ new section
  10. (diff | hist) 09:47 Talk:Sharps disposal 400 +363 Hedgerow_Hal (talk | contribs) /* Register: §Improvised containers reads as instruction */ new section